Traveler's Diarrhea pipeline therapeutics constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by Companies and remaining by the Universities Institutes.
Traveler's Diarrhea - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Traveler's Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Traveler's Diarrhea Traveler's diarrhea is a stomach and intestinal infection that occurs as a result of unsanitary handling of food. Symptoms include abdominal cramps, nausea, vomiting and fever. Predisposing factors include age, weakened immune systems, diabetes or inflammatory bowel disease and acid blockers or antacids.
Treatment includes anti-motility agents and antibiotics. The molecules developed by Companies in Phase III, Phase II and Preclinical stages are 2, 2 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 1 and 1 molecules, respectively.
Furthermore, this report also reviews of key players involved in therapeutic development for Traveler's Diarrhea and features dormant and discontinued projects.
Key Topics Covered:
- Traveler's Diarrhea Overview
- Therapeutics Development
- Pipeline Products for Traveler's Diarrhea - Overview
- Pipeline Products for Traveler's Diarrhea - Comparative Analysis
- Traveler's Diarrhea - Therapeutics under Development by Companies
- Traveler's Diarrhea - Therapeutics under Investigation by Universities/Institutes
- Traveler's Diarrhea Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Traveler's Diarrhea - Products under Development by Companies
- Traveler's Diarrhea - Products under Investigation by Universities/Institutes
- Traveler's Diarrhea - Companies Involved in Therapeutics Development
- Cosmo Pharmaceuticals NV
- GlaxoSmithKline Plc
- Nippon Shinyaku Co., Ltd.
- Prokarium Limited
- Scandinavian Biopharma Holding AB
- Sigmoid Pharma Limited
For more information about this report visit http://www.researchandmarkets.com/research/qcvkxp/travelers